Andrew Hull - Net Worth and Insider Trading
Andrew Hull Net Worth
The estimated net worth of Andrew Hull is at least $10,251 dollars as of 2024-09-20. Andrew Hull is the Director of InMed Pharmaceuticals Inc and owns about 38,258 shares of InMed Pharmaceuticals Inc (INM) stock worth over $10,251. Details can be seen in Andrew Hull's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Hull has not made any transactions after 2024-02-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Hull
Andrew Hull Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Hull owns 1 companies in total, including InMed Pharmaceuticals Inc (INM) .
Click here to see the complete history of Andrew Hull’s form 4 insider trades.
Insider Ownership Summary of Andrew Hull
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2024-02-21 | director |
Andrew Hull Latest Holdings Summary
Andrew Hull currently owns a total of 1 stock. Andrew Hull owns 38,258 shares of InMed Pharmaceuticals Inc (INM) as of February 21, 2024, with a value of $10,251.
Latest Holdings of Andrew Hull
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2024-02-21 | 38,258 | 0.27 | 10,251 |
Holding Weightings of Andrew Hull
Andrew Hull Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Hull has made a total of 1 transactions in InMed Pharmaceuticals Inc (INM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in InMed Pharmaceuticals Inc is the acquisition of 37,500 shares on February 21, 2024, which cost Andrew Hull around $14,625.
Insider Trading History of Andrew Hull
- 1
Andrew Hull Trading Performance
GuruFocus tracks the stock performance after each of Andrew Hull's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Hull is -18.41%. GuruFocus also compares Andrew Hull's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Hull within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Hull's insider trading performs compared to the benchmark.
Performance of Andrew Hull
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.73 |  | | | | |
| Relative Return to S&P 500(%) | -13.94 | | | | | |
Andrew Hull Ownership Network
Andrew Hull Owned Company Details
What does InMed Pharmaceuticals Inc do?
Who are the key executives at InMed Pharmaceuticals Inc?
Andrew Hull is the director of InMed Pharmaceuticals Inc. Other key executives at InMed Pharmaceuticals Inc include Sr VP & Clinical Reg Affairs Mancini Alexandra Diane Janet , director & President & CEO Eric A Adams , and Interim CFO Jonathan Tegge .
InMed Pharmaceuticals Inc (INM) Insider Trades Summary
Over the past 18 months, Andrew Hull made 1 insider transaction in InMed Pharmaceuticals Inc (INM) with a net purchase of 37,500. Other recent insider transactions involving InMed Pharmaceuticals Inc (INM) include a net purchase of 41,600 shares made by Eric A Adams , a net sale of 240 shares made by Mancini Alexandra Diane Janet ,
In summary, during the past 3 months, insiders sold 240 shares of InMed Pharmaceuticals Inc (INM) in total and bought 0 shares, with a net sale of 240 shares. During the past 18 months, 240 shares of InMed Pharmaceuticals Inc (INM) were sold and 79,100 shares were bought by its insiders, resulting in a net purchase of 78,860 shares.
InMed Pharmaceuticals Inc (INM)'s detailed insider trading history can be found in Insider Trading Tracker table.
InMed Pharmaceuticals Inc Insider Transactions
Andrew Hull Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Hull. You might contact Andrew Hull via mailing address: C/o Inmed Pharmaceuticals Inc., Suite 310 - 815 Hastings Street, Vancouver A1 V6c 1b4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
